Lymphoma Classifications, How to Develop a Future Unified Taxonomy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Evolving molecular classification of aggressive B-cell lymphoma.
Alig S, Chapuy B, Ennishi D, Dunleavy K, Hodson D Histopathology. 2024; 86(1):94-105.
PMID: 39545339 PMC: 11648360. DOI: 10.1111/his.15350.
References
1.
Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E
. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748.
PMC: 9214472.
DOI: 10.1038/s41375-022-01620-2.
View
2.
Au-Yeung R, Arias Padilla L, Zimmermann M, Oschlies I, Siebert R, Woessmann W
. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020; 190(5):753-763.
DOI: 10.1111/bjh.16578.
View
3.
Owen R, Treon S, Al-Katib A, Fonseca R, Greipp P, McMaster M
. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003; 30(2):110-5.
DOI: 10.1053/sonc.2003.50082.
View
4.
de Leval L, Alizadeh A, Bergsagel P, Campo E, Davies A, Dogan A
. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022; 140(21):2193-2227.
PMC: 9837456.
DOI: 10.1182/blood.2022015854.
View
5.
Horn H, Ziepert M, Becher C, Barth T, Bernd H, Feller A
. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood. 2013; 121(12):2253-63.
DOI: 10.1182/blood-2012-06-435842.
View